Skip to main content
. 2019 Mar 17;12(5):764–774. doi: 10.1016/j.tranon.2019.02.014

Figure 4.

Figure 4

Mutated genes with increased frequencies were ranked in ER-positive/HER2-negative and ER-positive / HER2-positive PD patients. Dark blue represents the most common increased mutations in PD patients.

(A) Rank of mutated ctDNA genes with increased frequencies in ER-positive/HER2-negative PD patients (n=3, left) and in individual PD patients (ID=4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 16, 33).

(B) Rank of increased mutation ctDNA genes in ER-positive/HER2-positive PD patients (n=4, left) and in individual PD patients (ID=25, 26, 27, 36).